NASDAQ
Total Transactions
1
0 buys /1 sells
Shares Acquired
0
Transactions: 0•Avg: 0
Shares Disposed
20,000
Transactions: 1•Avg: 20,000
Net Activity
-20,000
Net Selling•Ratio: 0%
Q4 2025(Current) | 0 | 20,000 | -20,000 | 0.00% |
Q3 2025 | 0 | 40,000 | -40,000 | 0.00% |
Q2 2025 | 0 | 141,122 | -141,122 | 0.00% |
Q1 2025 | 987,946 | 778,984 | +208,962 | 50.00% |
Q4 2024 | 200,398 | 64,161 | +136,237 | 70.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q4 2025
Acquired vs Disposed Shares
Net Distribution: 20,000 shares•Acquired/Disposed Ratio: 0%
Net Activity | |||||
|---|---|---|---|---|---|
ACR Anzalone Christopher Richard | Director, officer: chief executive officer | 24 | 807,049 | 958,340 | -151,291 |
OP O'Brien Patrick | Officer: coo and general counsel | 8 | 185,000 | 60,025 | +124,975 |
MKA Myszkowski Kenneth Allen | Officer: chief financial officer | 10 | 175,000 | 101,271 | +73,729 |
SMJ San Martin Javier | Officer: chief medical officer | 4 | 75,000 | 8,303 | +66,697 |
OT Oliver Tracie | Officer: chief commercial officer | 3 | 75,000 | 9,468 | +65,532 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-12-05 | Director | Sale | 16,250 | $61.03 | $991,737.5 | 115,240 | |
2025-11-28 | Director | Sale | 8,750 | $56.39 | $493,412.5 | 68,764 | |
2025-10-01 | Officer: chief medical officer | Sale | 20,000 | $35 | $700,000 | 212,122 | |
2025-09-12 | Officer: chief medical officer | Sale | 15,000 | $30 | $450,000 | 232,122 | |
2025-09-02 | Officer: chief medical officer | Sale | 15,000 | $25 | $375,000 | 247,122 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
PMS PERRY MICHAEL S | Director | Dec 9, 2025 | |
FM Ferrari Mauro | Director | Dec 1, 2025 | |
HJC Hamilton James C | Officer: chief medical officer | Oct 3, 2025 | |
HJC Hamilton James C | Officer: chief medical officer | Sep 16, 2025 | |
HJC Hamilton James C | Officer: chief medical officer | Sep 4, 2025 |
Net change in shares shown on right
No price data available for this timeframe.